Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation-Reference-Cited by-同舟云学术

Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation

Published:2016-04-25 Issue:23 Volume:7 Page:33901-33918
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Severson Tesa M.¹,Nevedomskaya Ekaterina¹²,Peeters Justine³,Kuilman Thomas⁴,Krijgsman Oscar⁴,van Rossum Annelot¹,Droog Marjolein¹,Kim Yongsoo¹²,Koornstra Rutger⁵,Beumer Inès³,Glas Annuska M.³,Peeper Daniel⁴,Wesseling Jelle¹,Simon Iris M.³,Wessels Lodewyk²,Linn Sabine C.¹⁶⁷,Zwart Wilbert¹

Affiliation:

1. Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands

2. Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands

3. Agendia NV, Amsterdam, XH, The Netherlands

4. Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands

5. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, GA, The Netherlands

6. Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands

7. Department of Pathology, University Medical Center Utrecht, CX, The Netherlands

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions;Genome Research;2024-05-06

2. Breast cancer risk SNPs converge on estrogen receptor binding sites commonly shared between breast tumors to locally alter estrogen signalling output;2023-11-02

3. Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer;Life Sciences;2021-12

4. Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer;Pharmaceutics;2021-05-07

5. Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancer;Molecular Aspects of Medicine;2021-04